Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Surya Semesta Internusa Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Surya Semesta Internusa Tbk. diperdagangkan di Rp1.825 (kapitalisasi pasar 8,19 T, volume 24 jam 58,98 jt). Perbedaan utamanya: Surya Semesta Internusa Tbk. jauh lebih besar — sekitar 47,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Surya Semesta Internusa Tbk. lebih aktif diperdagangkan (58,98 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SSIA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 8,19 T |
Volume | 592,2 rb | 58,98 jt |
Lot | 5,92 rb | 589,76 rb |
Perputaran | 147,05 jt | 107,58 M |
Harga Rata-rata | 248,31 | 1.824,13 |
Nilai Transaksi | 147,05 jt | 107,58 M |
Harga Ekuilibrium Indikatif | 254 | 1.825 |
Volume Ekuilibrium Indikatif | 10 | 4,74 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Selengkapnya di halaman SSIA →